BriefCase vs DeepHealth

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase

by Aidoc

DeepHealth

by RadNet, Inc.

AI Verdict

Aidoc's BriefCase is primarily a communication and collaboration solution that leverages AI for critical finding detection and workflow triage in medical imaging. DeepHealth, on the other hand, focuses on AI-powered health informatics solutions for improving diagnostic accuracy and operational efficiency across various imaging modalities and disease areas, including specific AI tools for cancer detection and neuroimaging analysis. While both operate in the radiology AI space, BriefCase emphasizes communication and workflow, whereas DeepHealth focuses on diagnostic assistance and broader operational improvements within imaging.

Choose BriefCase if…

Choose BriefCase if your primary need is to streamline communication and collaboration among care teams regarding critical medical imaging findings. Its strength lies in real-time, secure sharing of AI-detected urgent cases, ensuring timely follow-up and comprehensive audit trails for all communications.

View BriefCase →

Choose DeepHealth if…

Choose DeepHealth if your focus is on enhancing diagnostic accuracy and operational efficiency across a broad range of imaging modalities and disease areas, particularly in oncology and neurology. Its suite of AI-powered solutions for breast, prostate, lung, neurodegenerative, and thyroid nodule detection, along with AI-powered reporting, makes it ideal for improving diagnostic workflows.

View DeepHealth →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase	DeepHealth
Pricing	Enterprise pricing starts at approximately $50,000 per site per year and scales modularly.	Contact for pricing
Deployment	Aidoc's aiOS™ platform integrates seamlessly into a facility’s existing IT infrastructure, including PACS, EHR, VNA, scheduling systems, and radiology worklists, using standard communication protocols (DICOM, HL7, FHIR). It can be set up in 2 to 3 weeks, with some implementations as fast as 24 hours for rapid and efficient deployment.	Cloud-native or hybrid platform
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase

BriefCase emphasizes secure, real-time communication and mobile access for care team collaboration, suggesting a focus on intuitive workflows for busy clinicians. DeepHealth, while offering various AI suites, doesn't explicitly detail its user interface or collaboration features, making it harder to assess its direct usability for communication.

Clinical Value

DeepHealth

DeepHealth offers a broader range of AI-powered detection capabilities across multiple specialties and disease areas (breast, prostate, lung, neuro, thyroid), directly impacting diagnostic accuracy. BriefCase's clinical value is primarily in streamlining communication of findings, which is crucial but secondary to the initial diagnostic power.

Pricing & Value

Tie

Both tools utilize enterprise or 'contact for pricing' models, making a direct comparison of pricing and value difficult without specific quotes. Both aim to deliver significant value to large healthcare systems, but the lack of transparency prevents a definitive winner.

Enterprise Readiness

BriefCase

BriefCase explicitly states integration with PACS, RIS, and EHR systems, along with comprehensive audit trails and customizable communication protocols, indicating a strong focus on enterprise-level deployment and compliance. DeepHealth mentions a cloud-native or hybrid platform and an operating system, but less detail on specific enterprise integration features.

Innovation

DeepHealth

DeepHealth demonstrates innovation through its extensive suite of AI-powered detection tools across various imaging modalities and disease areas, including a cloud-native operating system and remote scanning. BriefCase's innovation lies in its AI-driven communication, but DeepHealth's breadth of diagnostic AI solutions appears more innovative in core AI application.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details regarding the level of customer support, training, or documentation available for either BriefCase or DeepHealth. Without this information, it's not possible to pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase	DeepHealth
Company	Aidoc Medical	RadNet, Inc.
Tagline	AI-driven communication and collaboration for critical medical imaging findings.	Empowering breakthroughs in care through imaging.
Categories	Clinical Decision Support & Reference, Radiology & Imaging AI	Clinical Decision Support & Reference, Oncology AI, Radiology & Imaging AI
Specialties	Cardiology, Emergency Medicine, Neurology, Pulmonology, Radiology	Neurology, Oncology, Radiology
Mobile App	both	Not specified
API Available	yes	Not specified

Videos

Demos, reviews, and walkthroughs featuring BriefCase and DeepHealth.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing physician workflows and EHR systems?

BriefCase by Aidoc is designed to integrate seamlessly with PACS, RIS, and EHR systems, offering a unified platform for AI-driven critical finding detection and communication. DeepHealth, with its DeepHealth OS, also aims to unify data across clinical and operational workflows, integrating with existing systems and supporting migration of templates for a more intelligent reporting experience.

What is the scope of clinical specialties and conditions each tool addresses with its AI capabilities?

BriefCase, as part of the Aidoc platform, focuses on critical medical imaging findings across specialties like Cardiology, Emergency Medicine, Neurology, and Pulmonology, primarily for radiology workflows. DeepHealth offers a broader range of AI-powered solutions for specific disease areas, including breast cancer, prostate cancer, lung nodules, neurodegenerative changes, and thyroid nodules, with suites dedicated to each.

What kind of audit trail and accountability features do these tools offer for tracking communication and AI-driven insights?

BriefCase provides comprehensive audit trails for all communications, ensuring traceability of critical medical imaging findings and their dissemination among care teams. Aidoc's platform also facilitates patient management by tracking follow-up imaging recommendations. DeepHealth's DeepHealth OS is designed to create personalized AI-powered workspaces with access to integrated data in a secure environment, enhancing collaboration and efficiency, which would inherently support auditability of actions within the platform.

How do these tools support multi-site rollouts and ensure consistent performance across different clinical environments?

Aidoc's platform, including BriefCase, is custom-configured for each hospital and integrated with minimal IT effort, with an implementation time of two to three weeks, suggesting a streamlined process for multi-site deployment. DeepHealth's cloud-native DeepHealth OS is built to deliver the latest technology at scale and is currently used by over 350 customers worldwide, indicating its capability for large-scale diagnostic and screening programs across multiple sites.

What evidence is available regarding the accuracy and sensitivity of the AI findings generated by each tool?

Aidoc's solutions are supported by over 220 studies documenting their accuracy and ROI potential. For example, Aidoc's solution helped radiologists reduce the average turnaround time for CT scans of intracranial hemorrhages. DeepHealth's Breast Suite, for instance, demonstrated over 90% sensitivity and 88% specificity in identifying arterial calcifications in clinical performance testing. DeepHealth also highlights a Nature Health study validating a 21% increase in breast cancer detection rate with their applications.